|
|
|
NASCSA Prescription Monitoring
IntroductionPrescription monitoring programs are among the most effective tools available to states, to identify and prevent drug diversion at the prescriber, pharmacy and patient levels. Prescription monitoring programs collect prescription data from pharmacies and other dispensers in either paper or electronic format. Data is reviewed and analyzed for educational, public health and investigative purposes. States with prescription monitoring programs recognize the legitimate need for controlled pharmaceuticals in healthcare therefore, programs are not intended to interfere with the legitimate prescribing, dispensing or procuring of these drugs. NASCSA is strongly committed to supporting states in their development and operation of prescription monitoring programs. Model ActIn October 2002 the National Association of State Controlled Substances Authorities (NASCSA) and the Alliance of States with Prescription Monitoring Programs (Alliance) jointly adopted the Prescription Monitoring Program Model Act. The Model Act provides a statutory framework for establishing and operating a prescription monitoring program. Both organizations recommend that states use the Model Act to establish new and update existing monitoring programs.
The Model Act is a consensus document that reflects the best practices of states the currently run monitoring programs as well as the knowledge of many other states that have a longstanding interest in such programs. The prescription monitoring states cover half the U.S. individual and practitioner populations and have over one-hundred years of combined experience in operating monitoring programs.
Below you will find hyperlinks to two documents, one the Model Act itself and the second a background statement that explains the rationale for the development of the Model Act.
Prescription Monitoring Standards
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prescription Monitoring
PMP Info Compiled by NASCSA
|
|
|||||
![]() |
|
![]() |
|||
|
|

